BSX vs UGRO · P/E 20, rev $10.65B vs rev $71.5M
Boston Scientific Corp (BSX) versus Urban-Gro Inc (UGRO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Urban-Gro Inc (UGRO) is a broadcasting company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported UGRO revenue for 2023-12-31 was $71.5M. Net income was -$18.7M. Revenue was up 6.7% from 2022-12-31 to 2023-12-31. UGRO currently screens at market cap $4.9M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. UGRO currently screens at market cap $4.9M.
Not investment advice. Open the BSX and UGRO stock pages for the full models.
Not investment advice.